Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David L Rimm

Showing results (21-30 of 412) with videos related to

Pageof 42
Sort By:
Cancer|January 10, 2006
The value of onsite adequacy assessment of thyroid fine-needle aspirations is a function of operator experienceMohiedean Ghofrani, Danita Beckman, David L Rimm
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2008
A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkersRobert L Camp, Veronique Neumeister, David L Rimm
Archives of Pathology & Laboratory Medicine|December 28, 2022
The Pathologists' ConundrumDavid L Rimm, Sanja Dacic, Stuart J Schnitt
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 17, 2013
Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1)Vamsidhar Velcheti, David L Rimm, Kurt A Schalper
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2023
Tissue Age Affects Antigenicity and Scoring for the 22C3 Immunohistochemistry Companion Diagnostic TestAileen I Fernandez, Patricia Gaule, David L Rimm
Archives of Pathology & Laboratory Medicine|July 13, 2006
Immunohistochemistry and quantitative analysis of protein expressionMelissa Cregger, Aaron J Berger, David L Rimm
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 11, 2021
Standardization of PD-L1 immunohistochemistrySandra Martinez-Morilla, Myrto Moutafi, David L Rimm
Women'S Health (London, England)|November 2, 2011
Breast cancer misclassification: a major obstacle to treatment?Elisa Romeo, Mark D Gustavson, David L Rimm
Clinical Colorectal Cancer|November 27, 2002
Subjective differences in outcome are seen as a function of the immunohistochemical method used on a colorectal cancer tissue microarrayGina G Chung, Eric P Kielhorn, David L Rimm
JAMA Oncology|July 27, 2023
Classification of Breast Cancer According to ERBB2 Immunohistochemistry ScoresCharles J Robbins, Aileen I Fernandez, David L Rimm
Pageof 42

Showing results (21-30 of 412) with videos related to

Sort By:
Pageof 42
Cancer|January 10, 2006
The value of onsite adequacy assessment of thyroid fine-needle aspirations is a function of operator experienceMohiedean Ghofrani, Danita Beckman, David L Rimm
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2008
A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkersRobert L Camp, Veronique Neumeister, David L Rimm
Archives of Pathology & Laboratory Medicine|December 28, 2022
The Pathologists' ConundrumDavid L Rimm, Sanja Dacic, Stuart J Schnitt
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 17, 2013
Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1)Vamsidhar Velcheti, David L Rimm, Kurt A Schalper
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 16, 2023
Tissue Age Affects Antigenicity and Scoring for the 22C3 Immunohistochemistry Companion Diagnostic TestAileen I Fernandez, Patricia Gaule, David L Rimm
Archives of Pathology & Laboratory Medicine|July 13, 2006
Immunohistochemistry and quantitative analysis of protein expressionMelissa Cregger, Aaron J Berger, David L Rimm
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 11, 2021
Standardization of PD-L1 immunohistochemistrySandra Martinez-Morilla, Myrto Moutafi, David L Rimm
Women'S Health (London, England)|November 2, 2011
Breast cancer misclassification: a major obstacle to treatment?Elisa Romeo, Mark D Gustavson, David L Rimm
Clinical Colorectal Cancer|November 27, 2002
Subjective differences in outcome are seen as a function of the immunohistochemical method used on a colorectal cancer tissue microarrayGina G Chung, Eric P Kielhorn, David L Rimm
JAMA Oncology|July 27, 2023
Classification of Breast Cancer According to ERBB2 Immunohistochemistry ScoresCharles J Robbins, Aileen I Fernandez, David L Rimm
Pageof 42